The in vivo study of inflammasome NOD-like receptor protein 3 (NLRP3) as a starting point for the development of new innovative migraine drugs
Michela Argentieri, Simona Stragapede, Chiara Sturaro, Pietro Pola, Valentina Albanese, Salvatore Pacifico and 4 more